Increasing Contingency Management Success in Smoking Cessation
NCT ID: NCT00273793
Last Updated: 2012-06-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
328 participants
INTERVENTIONAL
2005-06-30
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contingency Management to Promote Smoking Cessation
NCT06456242
Internet-based Group Contingency Management to Promote Smoking Abstinence
NCT01181661
Smoking Cessation in Substance Abuse Treatment Patients: A Feasibility Study
NCT00408265
Preliminary Test of Reactive Carrot Incentives in a Practice Quit Environment With Contingency Management Incentives
NCT05072301
Contingency Management for Smoking Abstinence With Adolescent Smokers
NCT01056588
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Shaping intervention for hard-to-treat smokers
Contingency Management
incentives are available for reduced smoking on each study visit which occur each weekday.
2
fixed criterion intervention for hard-to-treat smokers
Contingency Management
incentives are available for reduced smoking on each study visit which occur each weekday.
3
Non contingent incentives available to hard to treat smokers
Contingency Management
incentives are available for reduced smoking on each study visit which occur each weekday.
4
Ascending incentives values used in Smokers with Early Success
Contingency Management
incentives are available for reduced smoking on each study visit which occur each weekday.
5
fixed value incentives are used in Smokers with Early Success
Contingency Management
incentives are available for reduced smoking on each study visit which occur each weekday.
6
Non contingent incentives are available to Smokers with Early Success
Contingency Management
incentives are available for reduced smoking on each study visit which occur each weekday.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Contingency Management
incentives are available for reduced smoking on each study visit which occur each weekday.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
National Institutes of Health (NIH)
NIH
The University of Texas Health Science Center at San Antonio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard J Lamb, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center at San Antonio
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Smoking Cessation Laboratory, Department of Psychiatry, UTHSCSA, 7703 Floyd Curl Drive
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
045-0013-195
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.